Medtronic's insulin pump recall gets FDA's highest-risk label
Mon, 07/15/2013 - 9:59am Mass Device  U.S. healthcare regulators
put their highest-risk Class I label on Medtronic's Paradigm
insulin infusion pump recall.  Medtronic logo    Medtronic
informed patients, healthcare providers and pharmacies in Canada
of the potential problem, to explain how to avoid it, according
to the Brampton Guardian.   Share this Story  The password field
is case sensitive.